Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
FATE
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -28.8%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
therapeutics
cell
price
nasdaq
analyst
clinical
analysts
target
their
2024
market
ratings
raises
employee
inducement
recent
date
pipeline
vesting
announced
FATE
Fate Therapeutics, Inc.
Stonvex
StonvexStonvexStonvexStonvex